Loading
Latest filing published 25 Jun 2026 for 넥스트바이오메디컬, €23k.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
남동흔 has a single filing on record, published on 25 June 2026: an open-market purchase in 넥스트바이오메디컬. One trade is not enough to describe a pattern. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration